Samir Messaoudi was born in Christmas 1976 in Mechtras, Kabylia (Algeria). He studied chemistry (M.S.) at the University of Blaise Pascal, Clermont Ferrand, France, and completed his Ph.D. in 2004 in the group of Professor Michelle Prudhomme on the synthesis of rebeccamycin, staurosporine, and granulatimide analogues as anticancer agents. He then worked as a Postdoctoral Fellow with Professor David. J. Aitken working in the total synthesis of microsclerodermin C. Following a second postdoctoral fellowship working with Dr. Mouad Alami/Professor J.-D. Brion at the Pharmacy Faculty of Châtenay Malabry (Paris Sud University), he was appointed as a CNRS Researcher (2006) and joined the group of therapeutic chemistry (Dr. Mouad Alami/Prof. J.-D. Brion) at the University of Paris 11. He obtained his Habilitation Diploma in January 2011, working mainly on the transition-metal catalyzed C-C and C-heteroatom bond forming methodologies and the preparation of molecules and molecular scaffolds of biological and therapeutic interest (Hsp90 inhibitors and vascular disrupting agents).
Biography Updated on 9 April 2012